Drug Prescriptions among Italian and Immigrant Pregnant Women Resident in Italy: A Cross-Sectional Population-Based Study.
drug prescription
immigrants
inappropriate prescribing
pharmacoepidemiology
pregnant women
prevalence
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
received:
15
02
2022
revised:
28
03
2022
accepted:
29
03
2022
entrez:
12
4
2022
pubmed:
13
4
2022
medline:
14
4
2022
Statut:
epublish
Résumé
Ensuring drug safety for pregnant women through prescription drug monitoring is essential. The aim of this study was to describe the prescription pattern of medicines among pregnant immigrant women from countries with high migratory pressure (HMPCs) compared to pregnant Italian women. The prevalence of drug prescriptions among the two study populations was analysed through record linkage procedures applied to the administrative databases of eight Italian regions, from 2016 to 2018. The overall prevalence of drug prescription was calculated considering all women who received at least one prescription during the study period. Immigrants had a lower prevalence of drug prescriptions before (51.0% vs. 58.6%) and after pregnancy (55.1% vs. 60. 3%). Conversely, during pregnancy, they obtained a slightly higher number of prescriptions (74.9% vs. 72.8%). The most prescribed class of drugs was the blood and haematopoietic organs category (category ATC B) (56.4% vs. 45.9%, immigrants compared to Italians), followed by antimicrobials (31.3% vs. 33.7%). Most prescriptions were appropriate, while folic acid administration 3 months before conception was low for both study groups (3.9% immigrants and 6.2% Italians). Progesterone seemingly was prescribed against early pregnancy loss, more frequently among Italians (16.5% vs. 8.1% immigrants). Few inappropriate medications were prescribed among antihypertensives, statins and anti-inflammatory drugs in both study groups.
Identifiants
pubmed: 35409869
pii: ijerph19074186
doi: 10.3390/ijerph19074186
pmc: PMC8998753
pii:
doi:
Substances chimiques
Prescription Drugs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Annu Rev Psychol. 2011;62:531-58
pubmed: 21126184
PLoS One. 2020 Feb 11;15(2):e0228378
pubmed: 32045416
Diabetes Metab Res Rev. 2021 Nov;37(8):e3453
pubmed: 33779043
Arch Womens Ment Health. 2017 Jun;20(3):449-462
pubmed: 28389934
Lancet. 2013 Apr 6;381(9873):1235-45
pubmed: 23541058
Public Health Rev. 2016 Dec 03;37:28
pubmed: 29450069
Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):995-1004
pubmed: 29920833
Ann Ist Super Sanita. 2013;49(2):209-18
pubmed: 23771265
F1000Res. 2019 Jun 20;8:
pubmed: 31249673
Drug Saf. 2010 Jul 1;33(7):593-604
pubmed: 20553060
Eur J Clin Pharmacol. 2008 Nov;64(11):1125-32
pubmed: 18685836
Ann Ist Super Sanita. 2017 Apr-Jun;53(2):118-124
pubmed: 28617257
Dan Med Bull. 2011 Oct;58(10):B4339
pubmed: 21975158
BMC Public Health. 2018 May 15;18(1):623
pubmed: 29764430
Pharmacoepidemiol Drug Saf. 2011 Sep;20(9):895-902
pubmed: 21774029
BJOG. 2006 May;113(5):559-68
pubmed: 16637899
Eur J Epidemiol. 2016 Jul;31(7):691-701
pubmed: 27461270
Midwifery. 2015 Sep;31(9):871-8
pubmed: 26026198
BMJ Open. 2014 Feb 17;4(2):e004365
pubmed: 24534260
Cochrane Database Syst Rev. 2019 Nov 20;2019(11):
pubmed: 31745982
Front Pharmacol. 2021 Jun 23;12:699062
pubmed: 34248644
Soc Sci Med. 2009 Feb;68(3):452-61
pubmed: 19042065
Cochrane Database Syst Rev. 2018 Oct 01;10:CD002252
pubmed: 30277556
J Antimicrob Chemother. 2010 Oct;65(10):2238-46
pubmed: 20716554
Eur J Clin Pharmacol. 2000 Jul;56(4):323-8
pubmed: 10954347
BJOG. 2017 Jan;124(1):132-140
pubmed: 27297096
Acta Obstet Gynecol Scand. 2009;88(5):599-605
pubmed: 19308810
BMC Public Health. 2020 Jun 30;20(1):1039
pubmed: 32605605